Literature DB >> 17704875

Antireflux surgery for patients with end-stage lung disease before and after lung transplantation.

W J Gasper1, M P Sweet, C Hoopes, L E Leard, M E Kleinhenz, S R Hays, J A Golden, M G Patti.   

Abstract

BACKGROUND: Gastroesophageal reflux disease (GERD) is prevalent among patients with end-stage lung disease (ESLD). This disease can lead to microaspiration and may be a risk factor for lung damage before and after transplantation. A fundoplication is the best way to stop reflux, but little is known about the safety of elective antireflux surgery for patients with ESLD. This study aimed to report the safety of laparoscopic fundoplication for patients with ESLD and GERD before or after lung transplantation.
METHODS: Between January 1997 and January 2007, 305 patients were listed for lung transplantation, and 189 patients underwent the procedure. In 2003, routine esophageal studies were added to the pretransplantation evaluation. After the authors' initial experience, gastric emptying studies were added as well.
RESULTS: A total of 35 patients with GERD or delayed gastric emptying were referred for surgical intervention. A laparoscopic fundoplication was performed for 32 patients (27 total and 5 partial). For three patients, a pyloroplasty also was performed. Two patients had a pyloroplasty without fundoplication. Of the 35 operations, 15 were performed before and 20 after transplantation. Gastric emptying of solids or liquids was delayed in 12 (92%) of 13 posttransplantation studies and 3 (60%) of 5 pretransplantation studies. All operations were completed laparoscopically, and 33 patients recovered uneventfully (94%). The median hospital length of stay was 2 days (range, 1-34 days) for the patients admitted to undergo elective operations. Hospitalization was not prolonged for the three patients who had fundoplications immediately after transplantation.
CONCLUSIONS: The results of this study show that laparoscopic antireflux surgery can be performed safely by an experienced multidisciplinary team for selected patients with ESLD before or after lung transplantation, and that gastric emptying is frequently abnormal and should be objectively measured in ESLD patients.

Entities:  

Mesh:

Year:  2007        PMID: 17704875     DOI: 10.1007/s00464-007-9494-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  17 in total

1.  Preoperative evaluation of patients with gastroesophageal reflux disease.

Authors:  M G Patti; P M Fisichella; S Perretta
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2001-12       Impact factor: 1.878

2.  Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant.

Authors:  Frank D'Ovidio; Lianne G Singer; Denis Hadjiliadis; Andrew Pierre; Thomas K Waddell; Marc de Perrot; Micheal Hutcheon; Linda Miller; Gail Darling; Shaf Keshavjee
Journal:  Ann Thorac Surg       Date:  2005-10       Impact factor: 4.330

3.  The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D.

Authors:  F D'Ovidio; M Mura; R Ridsdale; H Takahashi; T K Waddell; M Hutcheon; D Hadjiliadis; L G Singer; A Pierre; C Chaparro; C Gutierrez; L Miller; G Darling; M Liu; M Post; S Keshavjee
Journal:  Am J Transplant       Date:  2006-08       Impact factor: 8.086

4.  Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology.

Authors:  Anand P Tamhankar; Jeffrey H Peters; Giussepe Portale; Chih-Cheng Hsieh; Jeffrey A Hagen; Cedric G Bremner; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

5.  High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis.

Authors:  G Raghu; T D Freudenberger; S Yang; J R Curtis; C Spada; J Hayes; J K Sillery; C E Pope; C A Pellegrini
Journal:  Eur Respir J       Date:  2006-01       Impact factor: 16.671

6.  Nissen fundoplication improves gastric motility in patients with delayed gastric emptying.

Authors:  T M Farrell; W S Richardson; R Halkar; C P Lyon; K D Galloway; J P Waring; C D Smith; J G Hunter
Journal:  Surg Endosc       Date:  2001-02-06       Impact factor: 4.584

Review 7.  Antireflux surgery in the setting of lung transplantation: strategies for treating gastroesophageal reflux disease in a high-risk population.

Authors:  Matthew G Hartwig; James Z Appel; R Duane Davis
Journal:  Thorac Surg Clin       Date:  2005-08       Impact factor: 1.750

8.  Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.

Authors:  R W Tobin; C E Pope; C A Pellegrini; M J Emond; J Sillery; G Raghu
Journal:  Am J Respir Crit Care Med       Date:  1998-12       Impact factor: 21.405

9.  Laparoscopic fundoplication in elderly patients with gastroesophageal reflux disease.

Authors:  Pietro Tedesco; Errol Lobo; Piero M Fisichella; Lawrence W Way; Marco G Patti
Journal:  Arch Surg       Date:  2006-03

10.  Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility.

Authors:  J R Jamieson; H J Stein; T R DeMeester; L Bonavina; W Schwizer; R A Hinder; M Albertucci
Journal:  Am J Gastroenterol       Date:  1992-09       Impact factor: 10.864

View more
  18 in total

1.  Gastroesophageal reflux disease after lung transplantation: pathophysiology and implications for treatment.

Authors:  Christopher S Davis; Vidya Shankaran; Elizabeth J Kovacs; James Gagermeier; Daniel Dilling; Charles G Alex; Robert B Love; James Sinacore; P Marco Fisichella
Journal:  Surgery       Date:  2010-08-21       Impact factor: 3.982

Review 2.  A review of the potential applications and controversies of non-invasive testing for biomarkers of aspiration in the lung transplant population.

Authors:  C S Davis; J Gagermeier; D Dilling; C Alex; E Lowery; E J Kovacs; R B Love; P M Fisichella
Journal:  Clin Transplant       Date:  2010-03-19       Impact factor: 2.863

3.  Laparoscopic antireflux surgery for gastroesophageal reflux disease after lung transplantation.

Authors:  P Marco Fisichella; Christopher S Davis; James Gagermeier; Daniel Dilling; Charles G Alex; Jennifer A Dorfmeister; Elizabeth J Kovacs; Robert B Love; Richard L Gamelli
Journal:  J Surg Res       Date:  2011-06-22       Impact factor: 2.192

Review 4.  Pathophysiology of gastroesophageal reflux disease: how an antireflux procedure works (or does not work).

Authors:  Fernando A M Herbella; Francisco Schlottmann; Marco G Patti
Journal:  Updates Surg       Date:  2018-07-23

5.  Antireflux Surgery in Lung Transplant Patients.

Authors:  Marco Patti
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-03

6.  The Intersection of GERD, Aspiration, and Lung Transplantation.

Authors:  Marco G Patti; Marcelo F Vela; David D Odell; Joel E Richter; P Marco Fisichella; Michael F Vaezi
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2016-05-24       Impact factor: 1.878

7.  Idiopathic pulmonary fibrosis and gastroesophageal reflux. Implications for treatment.

Authors:  Marco E Allaix; Piero M Fisichella; Imre Noth; Fernando A Herbella; Bernardo Borraez Segura; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

8.  Both Pre-Transplant and Early Post-Transplant Antireflux Surgery Prevent Development of Early Allograft Injury After Lung Transplantation.

Authors:  Wai-Kit Lo; Hilary J Goldberg; Jon Wee; P Marco Fisichella; Walter W Chan
Journal:  J Gastrointest Surg       Date:  2016-01       Impact factor: 3.452

Review 9.  The pulmonary side of reflux disease: from heartburn to lung fibrosis.

Authors:  Marco E Allaix; P Marco Fisichella; Imre Noth; Bernardino M Mendez; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-04-25       Impact factor: 3.452

10.  Association of gastroesophageal reflux and O2 desaturation: a novel study of simultaneous 24-h MII-pH and continuous pulse oximetry.

Authors:  R Salvador; T J Watson; F Herbella; A Dubecz; M Polomsky; C E Jones; D R Raymond; J H Peters
Journal:  J Gastrointest Surg       Date:  2009-02-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.